20 related articles for article (PubMed ID: 29594992)
1. [Expression of interleukin-34 in tongue squamous cell carcinoma and its clinical implications].
Zhang W; Zou Z; Zhu Y; Wang M; Ma C; Wu J; Shi X; Liu X
Nan Fang Yi Ke Da Xue Xue Bao; 2023 Dec; 43(12):2111-2117. PubMed ID: 38189398
[TBL] [Abstract][Full Text] [Related]
2. High expression of proline-rich tyrosine kinase 2 is associated with poor survival of hepatocellular carcinoma via regulating phosphatidylinositol 3-kinase/AKT pathway.
Cao J; Chen Y; Fu J; Qian YW; Ren YB; Su B; Luo T; Dai RY; Huang L; Yan JJ; Wu MC; Yan YQ; Wang HY
Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S312-23. PubMed ID: 22618716
[TBL] [Abstract][Full Text] [Related]
3. FoxM1 promotes epithelial-mesenchymal transition, invasion, and migration of tongue squamous cell carcinoma cells through a c-Met/AKT-dependent positive feedback loop.
Yang H; Wen L; Wen M; Liu T; Zhao L; Wu B; Yun Y; Liu W; Wang H; Wang Y; Wen N
Anticancer Drugs; 2018 Mar; 29(3):216-226. PubMed ID: 29360662
[TBL] [Abstract][Full Text] [Related]
4. [Expression and clinical significance of VEGF-C and Flt-4 in tongue squamous cell carcinoma].
Li QL; Chen FJ; Zeng ZY; Yang AK; Wu QL; Zhang HZ; Hou JH
Ai Zheng; 2006 Feb; 25(2):235-40. PubMed ID: 16480594
[TBL] [Abstract][Full Text] [Related]
5. [Expression of Oct4 and Sox2 and their clinical significance in tongue squamous cell carcinoma].
Jiang XD; Luo G; Wang XH; Chen LL; Ke X; Li Y
Zhonghua Kou Qiang Yi Xue Za Zhi; 2017 Jan; 52(1):27-33. PubMed ID: 28072991
[No Abstract] [Full Text] [Related]
6. [Expression and significance of microRNA-125b in tongue squamous cell carcinoma].
Wang J; Yan GP; Guo C; Li J
Hua Xi Kou Qiang Yi Xue Za Zhi; 2020 Feb; 38(1):11-16. PubMed ID: 32037760
[TBL] [Abstract][Full Text] [Related]
7. Tyrosine kinase inhibitors for the treatment of rheumatoid arthritis.
Gomez-Puerta JA; Mócsai A
Curr Top Med Chem; 2013; 13(6):760-73. PubMed ID: 23574525
[TBL] [Abstract][Full Text] [Related]
8. Structure-based discovery of cellular-active allosteric inhibitors of FAK.
Tomita N; Hayashi Y; Suzuki S; Oomori Y; Aramaki Y; Matsushita Y; Iwatani M; Iwata H; Okabe A; Awazu Y; Isono O; Skene RJ; Hosfield DJ; Miki H; Kawamoto T; Hori A; Baba A
Bioorg Med Chem Lett; 2013 Mar; 23(6):1779-85. PubMed ID: 23414845
[TBL] [Abstract][Full Text] [Related]
9. TrkB is highly expressed in NSCLC and mediates BDNF-induced the activation of Pyk2 signaling and the invasion of A549 cells.
Zhang S; Guo D; Luo W; Zhang Q; Zhang Y; Li C; Lu Y; Cui Z; Qiu X
BMC Cancer; 2010 Feb; 10():43. PubMed ID: 20156366
[TBL] [Abstract][Full Text] [Related]
10. The significance of proline-rich tyrosine kinase2 (Pyk2) on hepatocellular carcinoma progression and recurrence.
Sun CK; Ng KT; Sun BS; Ho JW; Lee TK; Ng I; Poon RT; Lo CM; Liu CL; Man K; Fan ST
Br J Cancer; 2007 Jul; 97(1):50-7. PubMed ID: 17551499
[TBL] [Abstract][Full Text] [Related]
11. Variations of proline-rich kinase Pyk2 expression correlate with prostate cancer progression.
Stanzione R; Picascia A; Chieffi P; Imbimbo C; Palmieri A; Mirone V; Staibano S; Franco R; De Rosa G; Schlessinger J; Tramontano D
Lab Invest; 2001 Jan; 81(1):51-9. PubMed ID: 11204274
[TBL] [Abstract][Full Text] [Related]
12. [Expression and clinical significance of proline-rich tyrosine kinase 2 and phospho-protein kinase B in tongue squamous cell carcinoma].
Lingling L; Shengzhi W; Xuyang L; Hao L; Zhaohua G
Hua Xi Kou Qiang Yi Xue Za Zhi; 2018 Feb; 36(1):29-32. PubMed ID: 29594992
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
